Sign In
to Vote &
Create Storyboards.
 
Biocon shares rise 9% as breast cancer biosimilar gets USFDA panel nod Biocon stock soared 8.88% to settle at Rs399.20 on BSE
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard